Who is sponsoring NCT05644158?

NCT05644158 is sponsored by Medical University Innsbruck.

What drugs are being tested in NCT05644158?

Interventions in NCT05644158: Revascularization, Exercise therapy.

What condition does NCT05644158 study?

NCT05644158 studies Peripheral Arterial Disease, Cardiovascular Diseases.

Is NCT05644158 still recruiting?

NCT05644158 is currently status unknown. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT05644158: MIVA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mitochondrial Function in Peripheral Arterial Disease

Status unknown NA Last updated 13 March 2024

What this trial tests

NA trial testing Revascularization in Peripheral Arterial Disease in 80 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
31 December 2024

31 January 2025

Quick facts

Lead sponsor	Medical University Innsbruck
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	80
Start date	1 November 2022
Primary completion	31 December 2024
Estimated completion	31 January 2025
Sites	1 location across Austria

Drugs / interventions tested

Revascularization
Exercise therapy

Conditions studied

Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Medical University Innsbruck

Who can join

Adults 18 to 99, any sex, with Peripheral Arterial Disease or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of different treatment strategies on mitochondrial function and to correlate in-vitro results to findings from in-vivo measurements of mitochondrial function. The authors hypothesize that interventional revascularization and therefore the restoration of blood and oxygen supply is more relevant to mitochondrial function compared to the effect of exercise training.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Role of PTEN-Induced Protein Kinase 1 as a Mitochondrial Dysfunction Regulator in Cardiovascular Disease Pathogenesis.
Gwon JG, Lee SM. · · 2024 · cited 9× · PMID 38486493 · DOI 10.5758/vsi.230116
A Randomized Control Trial Investigating the Effect of Different Treatment Strategies on Mitochondrial Function in Peripheral Arterial Disease: A Study Protocol.
Schoenherr L, Heidler J, Kluckner M, Lobenwein D, et al · · 2025 · PMID 39987612 · DOI 10.1016/j.jss.2025.01.014

Verify or expand the search:

Other trials of Revascularization

Trials testing the same drug.

NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting
NCT06279663 — Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coro · NA · recruiting
NCT05570019 — Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD) · unknown
NCT04252950 — Community-based Exercise Following Revascularization for PAD · NA · recruiting
NCT04939038 — Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease · NA · terminated

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting

Other Medical University Innsbruck trials

Trials by the same sponsor.

NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05644158 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05644158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing